Year: 2015

UPCI Research Focus: Pediatric Cancers

UPCI investigators and physician-scientists within the Division of Pediatric Hematology/Oncology at Children’s Hospital of Pittsburgh of UPMC are engaged in ground-breaking research, both in the laboratory and in the clinic. Watch Linda McAllister-Lucas, MD, PhD, Chief of the Division of

SITC and Cancer Immunotherapy: When Vision Becomes Reality

The Society for the Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to professionals working in the field of cancer immunology and immunotherapy. A number of UPCI investigators are active members of this research community, and

Large NIH Grant Renewed for Pitt’s Center for Medical Countermeasures Against Radiation (CMCR)

Last month, the University of Pittsburgh Cancer Institute (UPCI) and Pitt’s School of Medicine and Graduate School of Public Health received a five-year, $18 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) to continue work developing

Dr. Thomas Kensler Named Outstanding Investigator by NCI, Awarded $6.3M for Studying How Food Can Lower Cancer Risks

Thomas Kensler, PhD, Professor of Pharmacology and Chemical Biology and Co-Leader of the UPCI Cancer Epidemiology and Prevention Program, was awarded a $6.3 million Outstanding Investigator Award from the National Cancer Institute (NCI). This new, 7-year award acknowledges experienced researchers

UPCI Academy Scholars Present Research Findings at Annual Poster Session

The 2015 UPCI Academy summer session came to a close on Friday, August 7, as the high school students presented their laboratory findings through oral and poster presentations at the Hillman Cancer Center. Watch several UPCI Academy Scholars describe their

Head and Neck Cancer Patients Receive Cutting-Edge Immunotherapies through UPCI Clinical Trials Robert L. Ferris, MD, PhD and Julie E. Bauman, MD, MPH

Multi-disciplinary clinicians and researchers at UPCI and UPMC CancerCenter are utilizing the power of the body’s immune system to fight tumors of the head and neck. Watch Robert L. Ferris, MD, PhD and Julie E. Bauman, MD, MPH discuss one

UPCI’s Pittsburgh Genome Resource Repository (PGRR) Offers a Powerful Tool for Cancer Researchers

Publically available genomic datasets, such as The Cancer Genome Atlas (TCGA) of the National Cancer Institute (NCI), are highly informative and can be used for numerous research purposes including discovery of new biomarkers, validation of new methods, and development of

Broccoli Sprout Extract Promising for Head and Neck Cancer Prevention

A new study led by UPCI head and neck cancer researchers has shown that broccoli sprout extract protects against oral cancer in mice and proved tolerable in a small group of healthy human volunteers. The promising results of this research,

UPCI Researchers Target Viruses that Cause Cancer

Of the many viruses that infect humans, only seven have been shown to cause cancer to date. Two of these known cancer-causing viruses, Kaposi’s sarcoma herpesvirus (KSHV) and Merkel cell polyomavirus (MCV), were discovered by Patrick Moore, MD, MPH, and

UPCI’s Tumor Microenvironment Center (TMC) Bridges Multiple Disciplines to Study External Influences on Tumors

Tumors do not grow in isolation, but are influenced by many surrounding factors in their environment. The Tumor Microenvironment Center (TMC) is a collaborative, multi-disciplinary effort that brings together preclinical and clinical scientists with the goal of translating basic knowledge

Top